Atorvastatin Calcium Tablet
Product Images NDC 70518-3848

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Atorvastat Cal Usp Structure)

"image Description" (Atorvastat Cal Usp Structure)
Chemical structure of atorvastatin calcium, depicting its molecular arrangement including aromatic rings, hydroxyl groups, a fluorophenyl group, and calcium ions with hydration.*
FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 1)

"image Description" (Atorvastat Cal Usp Fig 1)
A line graph showing cumulative incidence percentage over time in years for Atorvastatin versus placebo. The graph compares the incidence rates of events or outcomes between Atorvastatin (solid line) and placebo (dashed line), with lower incidence observed for Atorvastatin. Hazard ratio (HR) and p-value are provided on the graph at the bottom right.*
FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 2)

"image Description" (Atorvastat Cal Usp Fig 2)
A Kaplan-Meier curve chart showing cumulative hazard percentages over time (years) comparing Atorvastatin and placebo groups. The X-axis represents time to the first primary endpoint up to 4 years of follow-up, and the Y-axis shows cumulative hazard percentage. The Atorvastatin group has a lower cumulative hazard than the placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p-value of 0.001.*
FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 3)

"image Description" (Atorvastat Cal Usp Fig 3)
A line graph displaying the proportion of subjects experiencing a major cardiovascular event over time (up to 5 years) for two atorvastatin dosage groups: 10 mg (dashed line) and 80 mg (solid line). The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical comparison between the groups.*
FDA Label Image

Mm1 (Atorvastatin Calcium 80mg 70518 3848 00)

Mm1 (Atorvastatin Calcium 80mg 70518 3848 00)
Atorvastatin Calcium 80 mg oral tablets, pack of 90. The label shows the product name, strength, quantity, NDC (70518-3848-00), and indicates it is repackaged by RemedyRepack Inc., Indiana, PA. Additional details include storage instructions and a QR code.*
FDA Label Image

Mm2 (Atorvastatin Calcium 80mg 70518 3848 01)

Mm2 (Atorvastatin Calcium 80mg 70518 3848 01)
Label for Atorvastatin Calcium 80 mg oral tablets, packaged in a quantity of 30 tablets. The label shows the NDC number 70518-3848-01 and includes storage instructions to keep medication out of children's reach and store at 20-25°C. It also notes the product is repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Atorvastatin Calcium 80 mg oral tablets, quantity 90 tablets, labeled by Remedy Repack Inc. The label includes NDC 70518-3848-00, manufacturer information (Nivagen Pharmaceuticals, Inc., Sacramento, CA), and storage instructions. It features a barcode and a QR code for scanning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.